Labtician OphthalmicsLabtician Ophthalmics

Menu
  • International
  • About Us
  • For Patients
  • Buy Online
  • French
  • Surgical Products
  • Therapeutic Products
  • Product Search
  • Resources
  • Contact Us
  • Surgical Products
  • Therapeutic Products
  • Product Search
  • Resources
  • International
  • Contact Us
  • About Us
  • For Patients
  • Buy Online
  • English

Home / Webinars / The Value of Endoret PRGF – A Case Series Presentation

< Back

The Value of Endoret PRGF – A Case Series Presentation

September 15, 2023

Plasma Rich in Growth Factors (PRGF) is a personalised technology that has revolutionised the field of regenerative medicine. Its application has extended to many fields of medicine, from oral and maxillofacial surgery to dermatology, cosmetics, orthopaedic surgery and sports medicine. And more recently, optometry and ophthalmology over the last 15 years.

During this webinar Dr. Saama Sabeti, MD and Dr. Brittany Yelle, OD share their insights into managing the Endoret patient. They also discuss their personal clinical experience with Endoret demonstrating the value of Plasma Rich in Growth Factors (PRGF) to the patient.

Dr. Saama Sabeti, MD MPH FRCSC
Precision Cornea Centre
Cornea, Anterior Segment & Refractive
Dr. Brittany Yelle, OD
Precision Cornea Centre
Specialty Contact Lenses & Ocular Surface Disease

Want to learn more about the world’s most innovative surgical and therapeutic products? Need additional information about eye care solutions? Have questions? Get in touch with us today.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply
  • Home
  • Surgical Products
  • Therapeutic Products
  • Product Search
  • Resources
  • International
  • Contact Us
footer logo
© 2023 Labtician Ophthalmics, Inc. All rights reserved.
  • Terms of Service
  • Labtician Ophthalmics, Inc. Privacy Policy
  • Labtician Ophthalmics, Inc. Disclaimer
  • Labtician Ophthalmics Customer Service Policy
Website design and development by 1dea Design + Media Inc.